RedHill Biopharma Drug Gets FDA Boost for Treating Childhood Cancer
RedHill Biopharma's investigational drug opaganib has received FDA rare pediatric disease designation for treating neuroblastoma in children.
RedHill Biopharma
RedHill Says New Crohns Treatment May Reduce Side Effects
Israeli company RedHill Biopharma reports its experimental Crohn's treatment RHB-204 matches prior effectiveness with reduced ingredients for fewer side.
Navigation